Genopathy
Gene-Disorder Association · Article
Gene
MAP2K2
Mitogen-Activated Protein Kinase Kinase 2
Disorder
Melanoma
Manually curatedApproved treatment annotated
Association Review

In brief

The association between MAP2K2 (Mitogen-Activated Protein Kinase Kinase 2) and Melanoma is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 2
Compounds 5
Trials 230of 615 via MAP2K2 compounds
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
MAP2K2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Melanoma

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
06
Interventions

Therapeutics

5 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

615 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Provenance

References & sources

12 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access